companydata.dkcompanydata.dk

Afyx Therapeutics A/S: Financial statements 2025

CVR: 38793594

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

Afyx Therapeutics A/S (CVR 38793594) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 23,138,320 and a net result of DKK 1,518,132 compared with DKK -3,810,585 the year before. That is a decrease of 1.4% compared with the year before. Equity in the 2025 report amounted to DKK 36,178,254. The solvency ratio was 88.5%. The company had 5 employees in the financial year.

Gross Profit
DKK 23,138,320
Profit/Loss
DKK 1,518,132
Equity
DKK 36,178,254
Total Assets
DKK 40,860,660
Employees
5

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-23.1M1.5M36.2M5
2024-23.5M-3.8M9.7M11
2023-6.4M-2.3M4.7M5
2022--3.2M-7.3M-1M3
2021-1.5M-814K6.2M2

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Afyx Therapeutics A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

Afyx Therapeutics A/S: The 2024 annual report is outMay 27, 2025

Afyx Therapeutics A/S has published its annual report for 2024. Gross profit came to DKK 23,467,830, and the net result was DKK -3,810,585.

About Afyx Therapeutics A/S

Afyx Therapeutics A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2017. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Inphena A/S and Inphena ApS. The management consists of Claus Juan Møller-San Pedro. The board consists of Ole Baadsgaard (chair), Claus Juan Møller-San Pedro, Pia Leah Møller-San Pedro and Søren Mohrsen Kjær. The company is owned by Afyx Capital ApS. The company has 11 employees (2026). In 2025, the company reported a gross profit of DKK 23,138,320 and a net result of DKK 1,518,132 compared with DKK -3,810,585 the year before. Equity in the 2025 report amounted to DKK 36,178,254.

Source: annual report 2025, Danish Business Authority

Other financial years